The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Deep learning models go above and beyond traditional machine learning and can process data and recognize patterns much more ...

Live updates as Trump threatens tariffs on China, Mexico, Canada and BRICS countries. Follow the latest news on Cabinet picks ...

Josh Baer; Analyst; Morgan Stanley & Co. LLC Ryan MacDonald; Analyst; Needham & Company Inc.

Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an earnings per share (EPS) of $1.93 compared to the forecasted $1.77.